20170406 Telix Logo.png
Telix to Present at the 2021 Jefferies Virtual Healthcare Conference
June 01, 2021 08:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Chief Executive Officer, Dr. Christian...
20170406 Telix Logo.png
Telix Pharmaceuticals and AusHealth to Partner on Novel Therapeutics for Lung, Ovarian Cancer
October 29, 2019 19:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and ADELAIDE, Australia, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) has today announced that Telix and AusHealth have entered into a collaboration...
20170406 Telix Logo.png
Telix Pharmaceuticals to Present at Jefferies Healthcare Conference
June 03, 2019 08:54 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
20170406 Telix Logo.png
Telix and ANMI Expand PSMA Imaging Partnership
October 14, 2018 18:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
20170406 Telix Logo.png
Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging
October 14, 2018 18:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
20170406 Telix Logo.png
Science and Industry Endowment Fund Grant Awarded for Advanced Biologics Manufacturing
June 17, 2018 20:06 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, June 18, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
20170406 Telix Logo.png
Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange
November 14, 2017 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
20170406 Telix Logo.png
Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
November 08, 2017 18:20 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and...
20170406 Telix Logo.png
Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited
September 17, 2017 18:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been...